Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Oct 05, 2023 $15.04 $16.18 $14.90 $15.83 538 682
Oct 04, 2023 $16.84 $17.01 $15.14 $15.16 588 797
Oct 03, 2023 $15.98 $16.65 $15.70 $16.50 467 847
Oct 02, 2023 $16.46 $16.46 $15.68 $16.07 602 718
Sep 29, 2023 $17.74 $17.84 $16.14 $16.46 585 199
Sep 28, 2023 $17.54 $17.80 $17.21 $17.68 380 940
Sep 27, 2023 $17.23 $17.86 $17.21 $17.60 330 647
Sep 26, 2023 $16.94 $17.53 $16.74 $17.17 430 345
Sep 25, 2023 $17.01 $17.13 $16.61 $16.88 252 774
Sep 22, 2023 $17.62 $17.62 $17.10 $17.11 353 027
Sep 21, 2023 $17.42 $17.92 $17.16 $17.62 265 581
Sep 20, 2023 $17.92 $18.04 $17.56 $17.57 215 851
Sep 19, 2023 $17.79 $17.92 $17.58 $17.90 221 101
Sep 18, 2023 $17.95 $18.15 $17.65 $17.81 336 633
Sep 15, 2023 $18.18 $18.25 $17.61 $17.78 816 112
Sep 14, 2023 $17.85 $18.18 $17.84 $18.08 284 223
Sep 13, 2023 $17.35 $18.26 $17.28 $18.02 501 538
Sep 12, 2023 $17.24 $17.51 $17.10 $17.32 330 366
Sep 11, 2023 $17.17 $17.47 $16.93 $17.31 269 244
Sep 08, 2023 $17.36 $17.48 $17.09 $17.23 283 198
Sep 07, 2023 $17.48 $17.64 $17.25 $17.37 224 259
Sep 06, 2023 $17.41 $17.83 $17.23 $17.67 248 246
Sep 05, 2023 $18.07 $18.16 $17.37 $17.44 385 104
Sep 01, 2023 $17.81 $18.19 $17.81 $18.13 214 621
Aug 31, 2023 $18.39 $18.50 $17.67 $17.70 383 027
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT